| Product Code: ETC8856170 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Angioedema Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Angioedema Market - Industry Life Cycle |
3.4 Poland Angioedema Market - Porter's Five Forces |
3.5 Poland Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Poland Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Poland Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Poland Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Poland Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Poland Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Poland Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients |
4.2.2 Advancements in medical technology and treatments for angioedema |
4.2.3 Rising prevalence of angioedema cases in Poland |
4.3 Market Restraints |
4.3.1 High cost associated with angioedema treatments |
4.3.2 Limited availability of specialized healthcare facilities for angioedema management |
4.3.3 Lack of comprehensive reimbursement policies for angioedema treatments |
5 Poland Angioedema Market Trends |
6 Poland Angioedema Market, By Types |
6.1 Poland Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Poland Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Poland Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Poland Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Poland Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Poland Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Poland Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Poland Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Poland Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Poland Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Poland Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Poland Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Poland Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Poland Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Poland Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Poland Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Poland Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Poland Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Poland Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Poland Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Poland Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Poland Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Poland Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Poland Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Poland Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Poland Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Poland Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Poland Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Poland Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Poland Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Poland Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Poland Angioedema Market Import-Export Trade Statistics |
7.1 Poland Angioedema Market Export to Major Countries |
7.2 Poland Angioedema Market Imports from Major Countries |
8 Poland Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in angioedema diagnosis and management |
8.2 Patient adherence to prescribed treatment plans |
8.3 Rate of successful outcomes from angioedema treatments |
9 Poland Angioedema Market - Opportunity Assessment |
9.1 Poland Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Poland Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Poland Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Poland Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Poland Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Poland Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Poland Angioedema Market - Competitive Landscape |
10.1 Poland Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Poland Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here